Massive upregulation of the fas ligand in lpr and gld mice: Implications for fas regulation and the graft-versus-host disease-like wasting syndrome

Journal of Experimental Medicine

Volumn 181, Issue 1, 1995, Pages 393-398

  Chu, Jia Li ^a   Ramos, Paula ^a   Rosendorff, Adam ^a   Nikolć Zugić, Janko ^b   Lacy, Elizabeth ^b   Matsuzawa, Akio ^c   Elkon, Keith B ^a  

^a Department of Obstetrics Gynecology   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DNA; FC RECEPTOR; LIGAND; MESSENGER RNA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEDIATED CYTOTOXICITY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; LYMPH NODE CELL; LYMPHADENOPATHY; MOUSE; MUTATION; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

AGE FACTORS; ANIMAL; ANTIGENS, CD95; ANTIGENS, SURFACE; AUTOIMMUNE DISEASES; BASE SEQUENCE; CACHEXIA; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; GENE EXPRESSION; GRAFT VS HOST DISEASE; LYMPHATIC DISEASES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTE SUBSETS;

EID: 0028928654     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.181.1.393     Document Type: Article

References (29)

1. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.). 356: 314-317.
2. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lym-phoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76: 969-976.
3. Theofilopoulos, A.N., R.S. Balderas, Y. Gozes, M.T. Aguado, L. Hang, P.R. Morrow, and F.J. Dixon. 1985. Association of Ipr gene with graft-vs-host disease-like syndrome. J. Exp Med. 162: 1-18.
4. Fujiwara, M., and A. Kariyone. 1984. One way occurrence of graft-vs-host disease in bone marrow chimeras between congenic MRL mice. Immunology. 53: 251-256.
5. Ettinger, R.J., K.M. Wang, P. Bossu, K. Papas, C.L. Sidman, A.K. Abbas, and A. Marshak-Rothstein. 1994. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect. J. Immunol. 152: 1557-1568.
6. Hammond, D.M., P.S. Nagarkatti, L.R. Gote, A. Seth, M.R. Hassuneh, and M. Nagarkatti. 1994. Double-negative T cells from MRL-lpr/lpr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perforin gene. J. Exp Med. 178: 2225-2230.
7. Matsuzawa, A., T. Moriyama, T. Kaneko, M. Tanaka, M. Kimura, H. Ikeda, and T. Katagiri. 1990. A new allele of the lpr locus, lpf>, that complements the gld gene in induction of lymphadenopathy in the mouse. J. Exp Med. 171: 519-531.
8. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75: 1169-1178.
9. Kim, K.J., C. Kanellopoulos-Langevin, R.M. Merwin, D.H. Sachs, and R. Asofsky. 1979. Establishment and characterization of Balb/c lymphoma lines with B cell properties. J. Immunol. 122: 549-554.
10. Alt, F., N. Rosenberg, S. Lewis, E. Thomas, and D. Baltimore. 1981. Organization and reorganization of immunoglobulin genes in A-MulV-transformed cells: Rearrangement of heavy but not light chain genes. Cell. 27: 381-390.
11. Chu, J.-L., J. Drappa, A.P. Parnassa, and K.B. Elkon. 1993. The defect in Fas mRNA expression in MRL//pr mice is associated with insertion of the retrotransposon, ETn. J. Exp Med. 178: 723-730.
12. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
13. Drappa, J., N. Brot, and K.B. Elkon. 1993. The Fas protein is expressed at high levels on double positive thymocytes and activated mature T cells in normal but not MRL/lpr mice. Proc Natl. Acad. Sci. USA. 90: 10340-10344.
14. Allen, R.D., J.D. Marshall, J.R Roths, and C.L. Sidman. 1990. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J. Exp Med. 172: 1367-1375.
15. Anjelic, S., J. Drappa, L. Lacy, K.B. Elkon, and J. Nikolić-Zugić. 1994. The onset of Fas expression parallels the acquisition of CD8 and CD4 in fetal and adult alpha/beta thymo-cytes. Int. Immunol. 6: 73-79.
16. Cohen, P.L., and R.A. Eisenberg. 1991. lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Amu. Rev. Immunol. 9: 243-269.
17. Heron, L.R., R.A. Eisenberg, E. Roper, V. Kakkanaiah, R.L. Cohen, and B.L. Kotzin. 1993. Selection of the T cell repertoire in lpr mice. J. Immunol. 151: 3450-3459.
18. Theofilopoulos, A.N., and RJ. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-391.
19. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature (Lonl). 364: 806-809.
20. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl. Acad. Sci. USA. 90: 1756-1760.
21. Wu, J., T. Zhou, J. He, and J.D. Mountz. 1993. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp Med. 178: 461-468.
22. 2+-independent T cell-mediated cytotoxicity. J. Exp Med. 177: 195-200.
23. Stalder, T., S. Hahn, and P. Erb. 1994. Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J. Immunol. 152: 1127-1133.
24. Murray, L.J., R.L. Lee, and C. Martens. 1990. in vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur. J. Immunol. 20: 163-170.
25. Leithauser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Bruderlein, C. Henne, A. Schmidt, K.M. Debatin, P.H. Krammer, and P. Moller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/ tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69: 415-429.
26. Trauth, B.C., C. Klas, A.M.J. Peters, S. Matzko, P. Molla, W. Falk, K.M. Debatin, and P.H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by apoptosis. Science (Wash. DC). 245: 301-305.
27. Owen-Schuab, L.R, S. Yonehara, W.L. Crump, and E.A. Grim. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140: 197-205.
28. Klas, C., K.-M. Debatin, R.R. Jonker, and P.H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5: 625-630.
29. Ju, S.-T., H. Cui, D.J. Panka, R. Ettinger, and A. Marshak-Rothstein. 1994. Participation of target Fas protein in apoptosis pathway induced by CD4 + Thl and CD8 + cytotoxic T cells. Proc Natl. Acad. Sci. USA. 91: 4185-4189.